92 related articles for article (PubMed ID: 11343424)
1. The enhanced contractility of the phospholamban-deficient mouse heart persists with aging.
Slack JP; Grupp IL; Dash R; Holder D; Schmidt A; Gerst MJ; Tamura T; Tilgmann C; James PF; Johnson R; Gerdes AM; Kranias EG
J Mol Cell Cardiol; 2001 May; 33(5):1031-40. PubMed ID: 11343424
[TBL] [Abstract][Full Text] [Related]
2. The effect of isoproterenol on phospholamban-deficient mouse hearts with altered thyroid conditions.
Brittsan AG; Kiss E; Edes I; Grupp IL; Grupp G; Kranias EG
J Mol Cell Cardiol; 1999 Sep; 31(9):1725-37. PubMed ID: 10471356
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous measurement of intracellular calcium and ventricular function in the phospholamban-deficient mouse heart.
Hampton TG; Kranias EG; Morgan JP
Biochem Biophys Res Commun; 1996 Sep; 226(3):836-41. PubMed ID: 8831698
[TBL] [Abstract][Full Text] [Related]
4. Phospholamban modulates murine atrial contractile parameters and responses to beta-adrenergic agonists.
Kadambi VJ; Koss KL; Grupp IL; Kranias EG
J Mol Cell Cardiol; 1998 Jul; 30(7):1275-84. PubMed ID: 9710796
[TBL] [Abstract][Full Text] [Related]
5. Increased particulate partitioning of PKC epsilon reverses susceptibility of phospholamban knockout hearts to ischemic injury.
Gregory KN; Hahn H; Haghighi K; Marreez Y; Odley A; Dorn GW; Kranias EG
J Mol Cell Cardiol; 2004 Feb; 36(2):313-8. PubMed ID: 14871559
[TBL] [Abstract][Full Text] [Related]
6. Compensatory mechanisms associated with the hyperdynamic function of phospholamban-deficient mouse hearts.
Chu G; Luo W; Slack JP; Tilgmann C; Sweet WE; Spindler M; Saupe KW; Boivin GP; Moravec CS; Matlib MA; Grupp IL; Ingwall JS; Kranias EG
Circ Res; 1996 Dec; 79(6):1064-76. PubMed ID: 8943945
[TBL] [Abstract][Full Text] [Related]
7. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation.
Luo W; Grupp IL; Harrer J; Ponniah S; Grupp G; Duffy JJ; Doetschman T; Kranias EG
Circ Res; 1994 Sep; 75(3):401-9. PubMed ID: 8062415
[TBL] [Abstract][Full Text] [Related]
8. Proteomic analysis of hyperdynamic mouse hearts with enhanced sarcoplasmic reticulum calcium cycling.
Chu G; Kerr JP; Mitton B; Egnaczyk GF; Vazquez JA; Shen M; Kilby GW; Stevenson TI; Maggio JE; Vockley J; Rapundalo ST; Kranias EG
FASEB J; 2004 Nov; 18(14):1725-7. PubMed ID: 15358683
[TBL] [Abstract][Full Text] [Related]
9. Adenylyl cyclase type V deletion increases basal left ventricular function and reduces left ventricular contractile responsiveness to beta-adrenergic stimulation.
Tang T; Lai NC; Roth DM; Drumm J; Guo T; Lee KW; Han PL; Dalton N; Gao MH
Basic Res Cardiol; 2006 Mar; 101(2):117-26. PubMed ID: 16283593
[TBL] [Abstract][Full Text] [Related]
10. Sarcoplasmic reticulum calcium overloading in junctin deficiency enhances cardiac contractility but increases ventricular automaticity.
Yuan Q; Fan GC; Dong M; Altschafl B; Diwan A; Ren X; Hahn HH; Zhao W; Waggoner JR; Jones LR; Jones WK; Bers DM; Dorn GW; Wang HS; Valdivia HH; Chu G; Kranias EG
Circulation; 2007 Jan; 115(3):300-9. PubMed ID: 17224479
[TBL] [Abstract][Full Text] [Related]
11. Phospholamban gene ablation improves calcium transients but not cardiac function in a heart failure model.
Janczewski AM; Zahid M; Lemster BH; Frye CS; Gibson G; Higuchi Y; Kranias EG; Feldman AM; McTiernan CF
Cardiovasc Res; 2004 Jun; 62(3):468-80. PubMed ID: 15158139
[TBL] [Abstract][Full Text] [Related]
12. Thyroid hormone-induced alterations in phospholamban-deficient mouse hearts.
Kiss E; Brittsan AG; Edes I; Grupp IL; Grupp G; Kranias EG
Circ Res; 1998 Sep; 83(6):608-13. PubMed ID: 9742056
[TBL] [Abstract][Full Text] [Related]
13. Combined phospholamban ablation and SERCA1a overexpression result in a new hyperdynamic cardiac state.
Zhao W; Frank KF; Chu G; Gerst MJ; Schmidt AG; Ji Y; Periasamy M; Kranias EG
Cardiovasc Res; 2003 Jan; 57(1):71-81. PubMed ID: 12504816
[TBL] [Abstract][Full Text] [Related]
14. Phospholamban gene dosage effects in the mammalian heart.
Luo W; Wolska BM; Grupp IL; Harrer JM; Haghighi K; Ferguson DG; Slack JP; Grupp G; Doetschman T; Solaro RJ; Kranias EG
Circ Res; 1996 May; 78(5):839-47. PubMed ID: 8620604
[TBL] [Abstract][Full Text] [Related]
15. Gender differences in the modulation of cardiac gene expression by dietary conjugated linoleic acid isomers.
Tappia PS; Dent MR; Aroutiounova N; Babick AP; Weiler H
Can J Physiol Pharmacol; 2007; 85(3-4):465-75. PubMed ID: 17612656
[TBL] [Abstract][Full Text] [Related]
16. Exercise training improves the net balance of cardiac Ca2+ handling protein expression in heart failure.
Rolim NP; Medeiros A; Rosa KT; Mattos KC; Irigoyen MC; Krieger EM; Krieger JE; Negrão CE; Brum PC
Physiol Genomics; 2007 May; 29(3):246-52. PubMed ID: 17244791
[TBL] [Abstract][Full Text] [Related]
17. Altered calcium handling is critically involved in the cardiotoxic effects of chronic beta-adrenergic stimulation.
Engelhardt S; Hein L; Dyachenkow V; Kranias EG; Isenberg G; Lohse MJ
Circulation; 2004 Mar; 109(9):1154-60. PubMed ID: 14967726
[TBL] [Abstract][Full Text] [Related]
18. Enhanced cardiac function in mice overexpressing protein phosphatase Inhibitor-2.
Kirchhefer U; Baba HA; Bokník P; Breeden KM; Mavila N; Brüchert N; Justus I; Matus M; Schmitz W; Depaoli-Roach AA; Neumann J
Cardiovasc Res; 2005 Oct; 68(1):98-108. PubMed ID: 15975567
[TBL] [Abstract][Full Text] [Related]
19. Alterations of phospholamban function can exhibit cardiotoxic effects independent of excessive sarcoplasmic reticulum Ca2+-ATPase inhibition.
Schmitt JP; Ahmad F; Lorenz K; Hein L; Schulz S; Asahi M; Maclennan DH; Seidman CE; Seidman JG; Lohse MJ
Circulation; 2009 Jan; 119(3):436-44. PubMed ID: 19139388
[TBL] [Abstract][Full Text] [Related]
20. Phospholamban: a key determinant of cardiac function and dysfunction.
Rodriguez P; Kranias EG
Arch Mal Coeur Vaiss; 2005 Dec; 98(12):1239-43. PubMed ID: 16435604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
